Kanakasabai and co-workers showed that PPARD agonist (GW501516 and L165041) ameliorates the experimental autoimmune encephalomyelitis in C57BL/6 mice by inhibiting T helper type 1 (Th1) and Th17 responses (131). This evidence concerns the gene PPARD and experimental autoimmune encephalomyelitis.